Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00748
|
|||||
| Drug Name |
Linezolid
|
|||||
| Synonyms |
(S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide; 111GE017; Linezlid; Linezolid & VRC3375; Linezolid (JAN/USAN/INN); Linezolid [USAN:INN]; N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide; N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide; N-({5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide; N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide; NDA 21-130 Zyvox (linezolid tablets); NDA 21-131 Zyvox for injection (linezolid injection); NDA 21-132 Zyvox oral suspension (linzolid oral suspension); PNU 100766; PNU-100766; PNU-100766, U-100766, Zyvoxid, Zyvoxam, Linezolid; U 100766; U-100766; ZLD; Zyvox; Zyvox (TN); Zyvoxa; Zyvoxam; Zyvoxam (TN); Zyvoxid; Zyvoxid (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H20FN3O4
|
|||||
| Canonical SMILES |
CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F
|
|||||
| InChI |
InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1
|
|||||
| InChIKey |
TYZROVQLWOKYKF-ZDUSSCGKSA-N
|
|||||
| CAS Number |
CAS 165800-03-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 337.35 | Topological Polar Surface Area | 71.1 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
0.7
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.